Understanding immune responses to SARS-CoV-2 in lymphoma patients
SARS-CoV-2 immune responses in patients with lymphoma
This study is looking at how well people with non-Hodgkin lymphoma and chronic lymphocytic leukemia respond to COVID-19 vaccines, to better understand their immune responses and help improve vaccination strategies for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10886974 on NIH RePORTER |
What this research studies
This research investigates how patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia respond to SARS-CoV-2 vaccinations. It focuses on the immune system's ability to produce antibodies and T cells after vaccination, which is often impaired in these patients due to their cancer and its treatments. By analyzing blood samples from over 600 patients, the study aims to identify specific immune responses and how they relate to different lymphoma therapies. This information could help improve vaccination strategies for these vulnerable patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-Hodgkin lymphoma or chronic lymphocytic leukemia who are receiving or have received treatment.
Not a fit: Patients without a diagnosis of lymphoma or chronic lymphocytic leukemia are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better vaccination protocols that enhance immune responses in lymphoma patients, reducing their risk of severe COVID-19.
How similar studies have performed: Previous research has shown that immune responses to vaccines can vary significantly in cancer patients, indicating that this area of study is both relevant and necessary.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chang, Andres — Emory University
- Study coordinator: Chang, Andres
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.